Rsm Us Wealth Management »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Rsm Us Wealth Management

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Rsm Us Wealth Management from 13F filings

Historical chart of Rsm Us Wealth Management investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Rsm Us Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Rsm Us Wealth Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $37k 34k 1.10
2024-09-30 $19k 17k 1.12
2024-06-30 $19k 15k 1.28

More positions owned by Rsm Us Wealth Management

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Apple (AAPL)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Vanguard Index Fds Sml Cp Grw Etf (VBK)
Microsoft Corporation (MSFT)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
NVIDIA Corporation (NVDA)
Bank of America Corporation (BAC)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Eafe (IEFA)
Amazon (AMZN)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Rsm Us Wealth Management

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Ing Investment Management
Linden Advisors
Advent Capital Management
Calamos Advisors
Highbridge Capital Management
Tenor Capital Management
Davidson Kempner Capital Management
Bank Of Montreal
Lazard Asset Management
Magnetar Financial
State Street Corporation
Bank of America Corporation
Millennium Management
Point72 Asset Management
FMR

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1